Accès ouvert
2026
article
OpenAlex
Gyo Uchida, Masaki Nakamura, Kenji Makita, Hidenari Hirata et autres
Background Patients with early-stage non-small cell lung cancer (NSCLC) and comorbid interstitial lung disease (ILD) are at increased risk of severe pneumonitis. This study compared the clinical outcomes of stereotactic body radiation therapy (SBRT) and proton beam therapy (PBT) in this high-risk …
jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Kenji Makita, Hidehiro Hojo, Hidenari Hirata, Treshita Dey et autres
PURPOSE: This study evaluated the impact of neutrophil-to-lymphocyte ratio on the survival of patients with esophageal squamous cell carcinoma (ESCC) who underwent proton beam therapy with concurrent chemotherapy. MATERIALS AND METHODS: Data of patients with ESCC who received definitive proton beam therapy …
jp, in
(code pays fourni par la source)
Accès ouvert
2022
conference-paper
OpenAlex
Tetsuro Kakeshita, Kazuo Ishii, Yoshiharu Ishikawa, Hitoshi Matsubara et autres
jp
(code pays fourni par la source)
2017
article
OpenAlex
Toshiaki Iizuka, Gyo Uchida
jp
(code pays fourni par la source)
Accès ouvert
2016
preprint
OpenAlex
Toshiaki Iizuka, Gyo Uchida
In many medical care markets with limited profit potential, firms often have little incentive to innovate. These include the markets for rare diseases, "neglected" tropical diseases, and personalized medicine. Governments and not-for-profit organizations attempt to promote innovation in such markets, but empirical …
jp
(code pays fourni par la source)
Accès ouvert
2016
preprint
OpenAlex
Toshiaki Iizuka, Gyo Uchida
jp
(code pays fourni par la source)